KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Return on Invested Capital: 2024-2025

  • Recursion Pharmaceuticals' Return on Invested Capital was N/A to -0.58% in Q1 2025 from the same period last year, while for Mar 2025 it was -0.58%, marking a year-over-year change of. This contributed to the annual value of -0.63% for FY2024, which is 9.00% up from last year.
  • Latest data reveals that Recursion Pharmaceuticals reported Return on Invested Capital of -0.58% as of Q1 2025, which was up 4.74% from -0.61% recorded in Q4 2024.
  • In the past 5 years, Recursion Pharmaceuticals' Return on Invested Capital registered a high of -0.58% during Q1 2025, and its lowest value of -0.69% during Q3 2024.
  • Moreover, its 2-year median value for Return on Invested Capital was -0.61% (2024), whereas its average is -0.63%.